1. Home
  2. MRCY vs LEGN Comparison

MRCY vs LEGN Comparison

Compare MRCY & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

HOLD

Current Price

$97.93

Market Cap

5.1B

Sector

N/A

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$29.02

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRCY
LEGN
Founded
1981
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.9B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MRCY
LEGN
Price
$97.93
$29.02
Analyst Decision
Buy
Strong Buy
Analyst Count
8
12
Target Price
$80.00
$61.33
AVG Volume (30 Days)
503.6K
2.3M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
72.69
N/A
EPS
N/A
N/A
Revenue
$912,020,000.00
N/A
Revenue This Year
$6.59
$42.68
Revenue Next Year
$9.56
$30.52
P/E Ratio
N/A
N/A
Revenue Growth
9.19
N/A
52 Week Low
$47.53
$16.24
52 Week High
$103.81
$45.30

Technical Indicators

Market Signals
Indicator
MRCY
LEGN
Relative Strength Index (RSI) 69.71 65.66
Support Level $73.27 $25.01
Resistance Level $103.81 $29.69
Average True Range (ATR) 4.57 2.17
MACD 0.79 -0.12
Stochastic Oscillator 97.15 82.32

Price Performance

Historical Comparison
MRCY
LEGN

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: